Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Obesity, Morbid

• Induction of Labor in Morbidly Obese Patients
• Study of Liraglutide (A Weight Loss Drug) in High Risk Obese Participants With Cognitive and Memory Issues
• GLP-1 Receptor Agonists Post-Bariatric Surgery (GRABS) Feasibility Trial
• The Use of Indocyanine Green to Visualize Blood Flow to the Gastrojejunostomy During Bariatric Surgery.
• Remimazolam vs Propofol as an Induction Agent for Morbid Obesity Patients
• Ondansetron and Gabapentin in Preventing Postoperative Nausea and Vomiting After Laparoscopic Sleeve Gastrectomy
• Weight Loss, Blood Sugar and Blood Lipid Effects of Tetrahydrocannabivarin (THCV) Impregnated Mucoadhesive Strips
• Two Different Regimens of Bemiparin as a Thromboprophylaxis in Morbidly Obese Surgical Patients
• Transversus Abdominis Plane (TAP) Block Using Liposomal Bupivacaine in Metabolic and Bariatric Surgery Patients
• Ondansetron, Baclofen and Gabapentin in Preventing Postoperative Nausea and Vomiting After Bariatric Surgery
• The Effects of Laparoscopic Guided Transversus Abdominis Plane (TAP) Block in Sleeve Gastrectomy Procedure.
• Antibiotics, Gastric Bypass, and the Microbiome
• Evaluation of Propofol Dosing Based on Total Body Weight Using Closes-loop Anaesthesia Delivery System
• Effect of Liraglutide on Weight Loss in Patients Who Have Undergone Revisional Bariatric Surgeries.
• Oxytocin vs Carbetocin at Cesarean Delivery in Women With Morbid Obesity
• Use of Mysimba in Patients With Weight Regain After Bariatric Surgery
• Inflammatory Response to Opioid Versus Opioid Free Anesthesia
• Analgesia Management in Bariatric Surgery
• Effect of Subcutaneous Semaglutide on Kidney Transplant Candidacy
• Efficacy of CPPLAI in Laparoscopic Sleeve Gastrectomy Patients
• Liraglutide for Low-responders After Bariatric Surgery
• Fiber and Metformin Combination Therapy in Adolescents With Severe Obesity and Insulin Resistance
• Ketamine Infusion vs Dexmedetomidine Infusion in Obese Patients Undergoing Bariatric Surgery
• Clinical Evaluation of Polyherbal Coded Formulation Obesecure for Leptin Regulation and Obesity Management
• Bariatric Arterial Embolization for Men Starting Hormones for Prostate Cancer
• Role of Pharmacotherapy in Counteracting Weight Regain in Adolescents With Severe Obesity
• Multimodal Analgesia Effect on Post Surgical Patient
• Pharmacokinetics of Rivaroxaban After Bariatric Surgery
• Effect of Metabolic Surgery on Live Birth Rate of Offspring in Obesity Polycystic Ovarian Syndrome Patients
• Adjunct Phentermine + Topiramate After Bariatric Surgery in 12-24 Year Olds
• Efficacy Of Quadratus Lumborum II Block For Laparoscopic Sleeve Gastrectomy
• SMART Use of Medication for the Treatment of Adolescent Severe Obesity
• Effectiveness of Dapagliflozin for Weight Loss
• Anesthetics and Cerebral Oxygenation in LSG
• Effectiveness and Tolerability of Phentermine in Patients Under Bariatric Surgery
• Erector Spinae Plane Block Versus Opioid Based General Anesthesia During Laparoscopic Bariatric Surgery
• ED90 for Hyperbaric Bupivacaine in Super Obese Parturients
• THE EFFECT OF HELICOBACTER PYLORI ERADICATION THERAPY TO GASTRIC WALL THICKNESS BEFORE THE LAPAROSCOPIC SLEEVE GASTRECTOMY
• Sedation of Morbidly Obese for Balloon Insertion
• Setmelanotide (RM-493), Melanocortin-4 Receptor (MC4R) Agonist, in Bardet-Biedl Syndrome (BBS) and Alström Syndrome (AS) Patients With Moderate to Severe Obesity
• Effects of LRYGB on Pharmacokinetics of Nine CYP Probe Drugs
• Setmelanotide for the Treatment of LEPR Deficiency Obesity
• Dosing Obese With Noxafil® Under a Trial (DONUT)
• The Effect of Timing of Intravenous Paracetamol Administration on Post-surgical Pain
• Intravenous Lidocaine in Bariatric Surgery.
• Use of Impedance Cardiography to Decrease the Risk of Pre-eclampsia in Obese Patients
• Micafungin Pharmacokinetics in Obese Patients
• DPE Technique in Labor Epidural for Morbidly Obese Women
• Setmelanotide Phase 2 Treatment Trial in Patients With Rare Genetic Disorders of Obesity
• Preoxygenation With Optiflow™ in Morbidly Obese Patients is Superior to Face Mask
• Preoperative Omega-3 Polyunsaturated Fatty Acids in Morbidly Obese to Reduce Liver Volume and Steatosis
• Aromatase Inhibitors and Weight Loss in Severely Obese Hypogonadal Male Veterans (Pilot)
• Effect of Bile Acids and Bile Acid Sequstrants on GLP-1 Secretion After Roux-en-Y Gastric Bypass
• Effect of Number of Meals on Metabolism After Weight Loss Surgery
• Bariatric Surgery and Pharmacokinetics of Amlodipine
• Effects of Bile Acids and Bile Acid Sequestrants on GLP-1 Secretion After Roux-en-Y Gastric Bypass
• Comparisons of iv Ibuprofen and iv Paracetamol During Bariatric Surgery
• Surgical Conditions During Laparoscopic Bariatric Surgery
• Preoperative Condition in Giant Obese Patients
• Sugammadex Dosage Based on Ideal Body Weight for Profound Rocuronium-induced Neuromuscular Blockade Reversal in Morbidly Obese Patients
• Bioavailability of Paracetamol, Amoxicillin and Talinolol Before, Immediately and One Year After Gastric Bypass Operation
• Enhancing Weight Loss Maintenance With GLP-1RA (BYDUREON™) in Adolescents With Severe Obesity
• Effects of Bile Acids on GLP-1 Secretion After Roux-en-Y Gastric Bypass
• Influence of Gut Hormones on Food Intake After Roux-en-Y Gastric Bypass Surgery
• Liposomal Amphotericin B (AmBisome) Pharmacokinetics Given as a Single Intravenous Dose to Obese Patients (ASPEN)
• Preventive Therapy With Ursodiol to Reduce the Incidence of Gallstones Formation in Patients After Bariatric Surgery
• Prophylaxis of Venous Thromboembolism After Bariatric Surgery
• Topiramate and Severe Obesity
• Vitamin Deficiencies and Suppletion in Morbid Obesity
• Omega-3 Fatty Acids in Bariatric Gastric Bypass Surgery: Effect on Liver Volume, Immune Response and Erythrocyte Function
• Laparoscopic Bariatric Surgery: Two Regimens of Venous Thromboprophylaxis: Prospective Randomized Study
• Laparoscopic Bariatric Surgery: Impact of Deep Neuromuscular Block on Surgical Conditions
• Comparing Anti-XA Levels in Post-Cesarean Patients Undergoing Enoxaparin Thromboprophylaxis
• Increased Cefazolin During Cesarean Delivery in Obese Population
• Does Residual Muscular Weakness Lead to an Increase in Respiratory Complications in Bariatric Patients?
• Intragastric Injections of Botox for the Treatment of Obesity
• Anidulafungin Pharmacokinetics Given as a Single Intravenous Dose to Obese Patients (ADOPT)
• VAS Correlation With BMI
• Effects of RM-493 on Energy Expenditure in Obese Individuals
• In-vitro Myometrial Contractility After Oxytocin Pre-exposure in Women With Advanced Maternal Age and Morbid Obesity
• Pharmacokinetics of Dexmedetomidine in Morbid Obesity
• Topiramate in Adolescents With Severe Obesity
• Glossopharyngeal Nerve Block for Awake Intubation
• Pharmacokinetics of Acetaminophen in Morbidly Obese Patients
• Ketamine in Bariatric Surgery
• Comparative Study of Sugammadex Versus Neostigmine for Reversal of Neuromuscular Blockade in Morbidly Obese Patients
• Efficiency of TISSEEL for Sleeve Gastrectomy Complications
• Treatment of Low Metabolic Rate Following Bariatric Surgery
• A High Resolution Pharmacokinetic/Pharmacodynamic Model of Propofol in Morbidly Obese Subjects
• Neuromuscular Blockade and Surgical Conditions
• Ursodeoxycholic Acid in Bariatric Surgery
• Pharmacokinetics of Propofol in Morbidly Obese Patients
• CYP3A4 Metabolism Before and After Surgery Induced Weight Loss Using Midazolam as Model Drug
• Efficacy of IV Acetaminophen in Acute Post-Operative Pain Control in Laparoscopic Roux-en-Y Gastric Bypass Surgery (LRYGBP) Patients
• Safety and Efficacy of Lean Body Weight-based IV Heparin Dosing in Obese/Morbidly Obese Patients
• Sevoflurane Versus Intravenous Anaesthetic Agents in Morbid Obese Patients
• Patients-Controlled Epidural Analgesia After Gastric Bypass for Morbid Obesity Using Morphine-Levobupivacaine Regimens
• Levothyroxine (L-T4) Absorption After Bariatric Surgery
• Pharmacokinetics in Morbid Obesity After Bariatric Surgery
• Intraoperative Fluid Management in Laparoscopic Bariatric Surgery
• GLP-1 Therapy for Weight Loss and Improved Glucose Tolerance in Obese Children
• Study of the Effect of the Drug Gabapentin on Postoperative Pain and Incidence of Postoperative Nausea and Vomiting
• The Effects of Exenatide After Gastric Restriction
• PET Imaging and Bariatric Surgery
• n-3 Polyunsaturated Fatty Acids in Obesity
• Replacement GH Therapy After Bariatric Surgery in Patients With Very Severe Obesity
• Clinical Proposal for the Comparison of Intraperitoneal Anesthetic to Injected Local Anesthetic
• Population PK/PD of Propofol in the Morbidly Obese Patient
• Study of Proton Pump Inhibitors (PPI) to Prevent Strictures After Gastric Bypass Surgery
• Study to Determine Effective Dosing of Fondaparinux in Obese Persons